Bio Preventive Medicine Corp. (TPEX:6810)
Taiwan · Delayed Price · Currency is TWD 20.10
-0.50 (-2.43%)
Sep 15, 2026, 1:56 PM CST
Bio Preventive Medicine Market Cap
Bio Preventive Medicine has a market cap or net worth of 1.09 billion as of September 15, 2026. Its market cap has decreased by -8.32% in one year.
Market Cap
1.09B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
20.10
ChartMarket Cap Chart
Since August 30, 2021, Bio Preventive Medicine's market cap has increased from 711.01M to 1.09B, an increase of 53.35%. That is a compound annual growth rate of 8.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 628.62M | -45.67% |
| Dec 31, 2025 | 1.16B | -22.00% |
| Dec 31, 2024 | 1.48B | 13.92% |
| Dec 29, 2023 | 1.30B | 8.31% |
| Dec 30, 2022 | 1.20B | -4.26% |
| Dec 30, 2021 | 1.26B | 76.61% |
| Aug 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeoCore Technology | 1.27B |
| Abnova (Taiwan) | 1.23B |
| LabTurbo Biotech | 1.11B |
| Enimmune | 1.11B |
| Holy Stone Healthcare | 1.08B |
| BiOptic | 1.07B |
| Level Biotechnology | 1.02B |
| TCI GENE | 947.21M |